Slow drip, big impact: new drug combo may save heart valve patients from surgery
NCT ID NCT07360717
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different clot-dissolving medicines in 100 adults whose mechanical heart valves became blocked by blood clots. One group received a very slow, low-dose infusion of alteplase over 24 hours (up to 72 hours), while the other received a slow infusion of streptokinase over 24 hours (up to 48 hours). The goal was to see which drug works better and has fewer side effects, offering a non-surgical option to restore valve function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOLYSED are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr.Sibasis Sahoo
Ahmedabad, Gujarat, 380016, India